Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Novel therapies for metastatic prostate cancer.
Jang A, Lanka SM, Ruan HT, Kumar HLS, Jia AY, Garcia JA, Mian OY, Barata PC. Jang A, et al. Among authors: jia ay. Expert Rev Anticancer Ther. 2023 Jul-Dec;23(12):1251-1263. doi: 10.1080/14737140.2023.2290197. Epub 2023 Dec 8. Expert Rev Anticancer Ther. 2023. PMID: 38030394 Review.
Use of the Decipher genomic classifier among men with prostate cancer in the United States.
Zaorsky NG, Proudfoot JA, Jia AY, Zuhour R, Vince R Jr, Liu Y, Zhao X, Hu J, Schussler NC, Stevens JL, Bentler S, Cress RD, Doherty JA, Durbin EB, Gershman S, Cheng I, Gonsalves L, Hernandez BY, Liu L, Morawski BM, Schymura M, Schwartz SM, Ward KC, Wiggins C, Wu XC, Shoag JE, Ponsky L, Dal Pra A, Schaeffer EM, Ross AE, Sun Y, Davicioni E, Petkov V, Spratt DE. Zaorsky NG, et al. Among authors: jia ay. JNCI Cancer Spectr. 2023 Aug 31;7(5):pkad052. doi: 10.1093/jncics/pkad052. JNCI Cancer Spectr. 2023. PMID: 37525535 Free PMC article.
Effect of Prior Prostate Directed Local Therapy on Response to Apalutamide in Metastatic Hormone Sensitive Prostate Cancer: A Secondary Analysis of the TITAN Study.
Roy S, Saad F, Malone S, Agarwal N, Mohamad O, Morgan SC, Malone J, Swami U, Jia AY, Gebrael G, Mendiratta P, Brown JR, Rao SK, Sun Y, Wallis CJD, Chi KN, Chowdhury S, Kishan AU, Spratt DE. Roy S, et al. Among authors: jia ay. Eur Urol. 2024 Apr;85(4):398-400. doi: 10.1016/j.eururo.2024.01.003. Eur Urol. 2024. PMID: 38485300 No abstract available.
Biochemical Recurrence Surrogacy for Clinical Outcomes After Radiotherapy for Adenocarcinoma of the Prostate.
Roy S, Romero T, Michalski JM, Feng FY, Efstathiou JA, Lawton CAF, Bolla M, Maingon P, de Reijke T, Joseph D, Ong WL, Sydes MR, Dearnaley DP, Tree AC, Carrier N, Nabid A, Souhami L, Incrocci L, Heemsbergen WD, Pos FJ, Zapatero A, Guerrero A, Alvarez A, San-Segundo CG, Maldonado X, Reiter RE, Rettig MB, Nickols NG, Steinberg ML, Valle LF, Ma TM, Farrell MJ, Neilsen BK, Juarez JE, Deng J, Vangala S, Avril N, Jia AY, Zaorsky NG, Sun Y, Spratt D, Kishan AU; Meta-Analysis of Randomized Trials in Cancer of the Prostate (MARCAP) Consortium Investigators. Roy S, et al. Among authors: jia ay. J Clin Oncol. 2023 Nov 10;41(32):5005-5014. doi: 10.1200/JCO.23.00617. Epub 2023 Aug 28. J Clin Oncol. 2023. PMID: 37639648 Free PMC article.
Artificial intelligence applications in prostate cancer.
Baydoun A, Jia AY, Zaorsky NG, Kashani R, Rao S, Shoag JE, Vince RA Jr, Bittencourt LK, Zuhour R, Price AT, Arsenault TH, Spratt DE. Baydoun A, et al. Among authors: jia ay. Prostate Cancer Prostatic Dis. 2024 Mar;27(1):37-45. doi: 10.1038/s41391-023-00684-0. Epub 2023 Jun 9. Prostate Cancer Prostatic Dis. 2024. PMID: 37296271 Review.
36 results